Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Non-Hodgkin;Hodgkin Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06607419
What this trial is testing

Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia

Who this might be right for
B-Cell Lymphoblastic Leukemia
Shanghai Jiao Tong University School of Medicine 90
Not applicableStudy completedNCT05900830
What this trial is testing

Therapy Program for Academic Skills in Children With Intellectual Disability

Who this might be right for
Intellectual Disability, MildEducational Problems
Beni-Suef University 20
Testing effectiveness (Phase 2)Study completedNCT01339572
What this trial is testing

Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation

Who this might be right for
Non-Hodgkin's LymphomaMultiple Myeloma
University of Florida 72
Not applicableUnknownNCT04109872
What this trial is testing

Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results.

Who this might be right for
Mantle Cell Lymphoma
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 25
Not applicableLooking for participantsNCT03375619
What this trial is testing

Long-term Follow-up Study of Patients Receiving CAR-T Cells

Who this might be right for
Chronic Lymphocytic LeukemiaLymphomas Non-Hodgkin's B-CellLymphoma, Small Lymphocytic+6 more
Medical College of Wisconsin 500
Testing effectiveness (Phase 2)UnknownNCT05290337
What this trial is testing

ZR-CHOP in DLBCL With Specific Gene Abnormality

Who this might be right for
Diffuse Large B Cell Lymphoma
Fudan University 62
Testing effectiveness (Phase 2)Looking for participantsNCT06760039
What this trial is testing

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
Sun Yat-sen University 112
Large-scale testing (Phase 3)Looking for participantsNCT04442412
What this trial is testing

Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

Who this might be right for
Diffuse Large B-Cell LymphomaElderly Patients
Fondazione Italiana Linfomi - ETS 430
Not applicableNot Yet RecruitingNCT07198373
What this trial is testing

Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma

Who this might be right for
B Cell Lymphoma
Beijing GoBroad Hospital 40
Testing effectiveness (Phase 2)UnknownNCT03502629
What this trial is testing

Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)

Who this might be right for
Peripheral T Cell Lymphoma
Genor Biopharma Co., Ltd. 86
Not applicableLooking for participantsNCT06508775
What this trial is testing

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

Who this might be right for
Melanoma Stage IIIB-cell Non Hodgkin LymphomaPediatric ALL+4 more
Miltenyi Biomedicine GmbH 40
Not applicableLooking for participantsNCT06396312
What this trial is testing

Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression

Who this might be right for
Depressive; Disorder, Major, Single Episode, Major, With Psychotic SymptomsDepressive; Disorder, Major, Single Episode, Major (Without Psychotic Symptoms)Depressive Disorder, Major, Recurrent, With Psychotic Symptoms+4 more
Max-Planck-Institute of Psychiatry
Very early researchLooking for participantsNCT07048353
What this trial is testing

CD30 CAR-T in the Treatment of CD30 Positive Lymphoma

Who this might be right for
LymphomaB Cell LymphomaCD30+ Peripheral T-cell Lymphoma
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd 15
Testing effectiveness (Phase 2)Study completedNCT02077166
What this trial is testing

Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Pharmacyclics LLC. 138
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Testing effectiveness (Phase 2)Ended earlyNCT00112723
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more
National Cancer Institute (NCI) 46
Not applicableStudy completedNCT00476229
What this trial is testing

Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies

Who this might be right for
LymphomaLeukemia
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03876769
What this trial is testing

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 121
Not applicableLooking for participantsNCT02537769
What this trial is testing

Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients

Who this might be right for
Tricuspid RegurgitationHeart Failure NYHA Class IIIHeart Failure NYHA Class IV
University of Washington 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03277729
What this trial is testing

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+20 more
Fred Hutchinson Cancer Center 53
Next Page
130